Celularity Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	6.18	0.74	0.23	13.97	37.24
Cash & Short-Term Investments	6.18	0.74	0.23	13.97	37.24
Cash Growth	736.72%	225.11%	-98.38%	-62.50%	-31.43%
Accounts Receivable	4.65	13.56	10.05	4.45	2.75
Other Receivables	-	-	2.07	2.51	2.49
Total Trade Receivables	4.65	13.56	12.12	6.97	5.23
Inventory	0.57	5.41	5.75	5.31	9.55
Other Current Assets	0.92	0.86	1.7	7.26	7.08
Total Current Assets	12.32	20.56	19.79	33.5	59.1
Net Property, Plant & Equipment	66.52	72.43	78.82	88.72	90.63
Other Intangible Assets	7.76	9.25	11	120.99	123.19
Goodwill	7.35	7.35	7.35	119.69	123.3
Other Long-Term Assets	13.39	23.1	26.93	38.16	17.91
Total Assets	107.33	132.68	143.89	401.07	414.13
Accounts Payable	26.42	23.3	14.14	5.81	9.32
Accrued Expenses	32.57	20.49	7.58	9.07	11.66
Short-Term Debt	14	6.36	39.24	37.6	-
Current Portion of Long-Term Debt	-	-	-	-	3.05
Unearned Revenue	5.26	3.53	2.83	2.27	2.2
Other Current Liabilities	2.51	-	3.5	7.33	-
Total Current Liabilities	80.76	53.68	67.3	62.09	26.23
Long-Term Debt	-	35.93	-	-	-
Long-Term Leases	26.9	26.55	26.18	27.99	-
Other Long-Term Liabilities	37.73	7.69	9.45	112.09	288.49
Total Long-Term Liabilities	64.63	70.17	35.63	140.08	288.49
Total Liabilities	145.39	123.85	102.93	202.17	314.71
Common Stock	0	0	0.02	0.02	0.01
Additional Paid-in Capital	953.42	908.52	882.73	844.37	763.09
Accumulated Other Comprehensive Income	-	-0.01	-	0.01	-
Retained Earnings	-991.48	-899.68	-841.79	-645.5	-663.68
Total Common Shareholders' Equity	-38.06	8.84	40.96	198.9	99.42
Shareholders' Equity	-38.06	8.84	40.96	198.9	99.42
Total Liabilities & Equity	107.33	132.68	143.89	401.07	414.13
Total Debt	40.9	68.84	65.42	65.59	3.05
Net Cash (Debt)	-34.73	-68.1	-65.19	-51.62	34.19
Net Cash Growth	-	-	-	-	-33.36%
Net Cash Per Share	-1.36	-3.11	-3.66	-3.44	5.10
Book Value	-38.06	8.84	40.96	198.9	99.42
Book Value Per Share	-1.49	0.40	2.30	13.28	14.83
Tangible Book Value	-53.17	-7.76	22.61	-41.79	-147.07
Tangible Book Value Per Share	-2.08	-0.35	1.27	-2.79	-21.93

SEC Filings: 10-K · 10-Q